Cole Hugh M 4/A
4/A · Jounce Therapeutics, Inc. · Filed Mar 17, 2022
Insider Transaction Report
Form 4/AAmended
Cole Hugh M
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+85,000→ 85,000 totalExercise: $7.56Exp: 2032-02-01→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The Stock Option will vest (i) as to 55,000 shares of the Stock Option, quarterly in 16 equal installments following January 1, 2022 and (ii) as to 30,000 shares of the Stock Option, on January 1, 2023.